202 related articles for article (PubMed ID: 31849109)
41. Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma.
Tian Z; You Y; Xiao M; Liu J; Xu G; Ma C; Du Z; Wang Y
Int J Med Sci; 2023; 20(1):125-135. PubMed ID: 36619222
[No Abstract] [Full Text] [Related]
42. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1.
Lim R; Jaramillo D; Poussaint TY; Chang Y; Korf B
AJR Am J Roentgenol; 2005 Mar; 184(3):962-8. PubMed ID: 15728625
[TBL] [Abstract][Full Text] [Related]
43. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
44. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
45. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
46. Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Fisher MJ; Blakeley JO; Weiss BD; Dombi E; Ahlawat S; Akshintala S; Belzberg AJ; Bornhorst M; Bredella MA; Cai W; Ferner RE; Gross AM; Harris GJ; Listernick R; Ly I; Martin S; Mautner VF; Salamon JM; Salerno KE; Spinner RJ; Staedtke V; Ullrich NJ; Upadhyaya M; Wolters PL; Yohay K; Widemann BC
Neuro Oncol; 2022 Nov; 24(11):1827-1844. PubMed ID: 35657359
[TBL] [Abstract][Full Text] [Related]
47. Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.
Wolters PL; Burns KM; Martin S; Baldwin A; Dombi E; Toledo-Tamula MA; Dudley WN; Gillespie A; Widemann BC
Am J Med Genet A; 2015 Sep; 167A(9):2103-13. PubMed ID: 25976979
[TBL] [Abstract][Full Text] [Related]
48. Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings.
Friedrich RE; Giese M; Schmelzle R; Mautner VF; Scheuer HA
J Craniomaxillofac Surg; 2003 Feb; 31(1):1-9. PubMed ID: 12553919
[TBL] [Abstract][Full Text] [Related]
49. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.
Dombi E; Solomon J; Gillespie AJ; Fox E; Balis FM; Patronas N; Korf BR; Babovic-Vuksanovic D; Packer RJ; Belasco J; Goldman S; Jakacki R; Kieran M; Steinberg SM; Widemann BC
Neurology; 2007 Feb; 68(9):643-7. PubMed ID: 17215493
[TBL] [Abstract][Full Text] [Related]
50. Facial plexiform neurofibroma in a child with neurofibromatosis type I: a case report.
Patil K; Mahima VG; Shetty SK; Lahari K
J Indian Soc Pedod Prev Dent; 2007 Mar; 25(1):30-5. PubMed ID: 17456965
[TBL] [Abstract][Full Text] [Related]
51. Thoracic tumors in children with neurofibromatosis-1.
Schorry EK; Crawford AH; Egelhoff JC; Lovell AM; Saal HM
Am J Med Genet; 1997 Sep; 74(5):533-7. PubMed ID: 9342207
[TBL] [Abstract][Full Text] [Related]
52. Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.
Prada CE; Rangwala FA; Martin LJ; Lovell AM; Saal HM; Schorry EK; Hopkin RJ
J Pediatr; 2012 Mar; 160(3):461-7. PubMed ID: 21996156
[TBL] [Abstract][Full Text] [Related]
53. Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.
Amani V; Riemondy KA; Fu R; Griesinger AM; Grimaldo E; De Sousa GR; Gilani A; Hemenway M; Foreman NK; Donson AM; Willard N
Acta Neuropathol Commun; 2023 Sep; 11(1):158. PubMed ID: 37770931
[TBL] [Abstract][Full Text] [Related]
54. [Neurofibroma with contralateral linear hyperpigmentation along Blaschko lines].
Winter T; Gall H; Krone W; Sterry W
Hautarzt; 1997 Jan; 48(1):51-4. PubMed ID: 9132390
[TBL] [Abstract][Full Text] [Related]
55. [Cutaneous manifestations of type 1 neurofibromatosis and their treatment].
Lantiéri L; Wolkenstein P
Ann Chir Plast Esthet; 1998 Aug; 43(4):445-54. PubMed ID: 9926476
[TBL] [Abstract][Full Text] [Related]
56. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.
Mautner VF; Hartmann M; Kluwe L; Friedrich RE; Fünsterer C
Neuroradiology; 2006 Mar; 48(3):160-5. PubMed ID: 16432718
[TBL] [Abstract][Full Text] [Related]
57. Microdont Developing Outside the Alveolar Process and Within Oral Diffuse and Plexiform Neurofibroma in Neurofibromatosis Type 1.
Friedrich RE; Scheuer HT; Zustin J; Luebke AM; Hagel C; Scheuer HA
Anticancer Res; 2021 Apr; 41(4):2083-2092. PubMed ID: 33813418
[TBL] [Abstract][Full Text] [Related]
58. Plexiform neurofibroma of uterus: a rare manifestation of neurofibromatosis 1.
Shahzad R; Younas F
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S22-3. PubMed ID: 24717994
[TBL] [Abstract][Full Text] [Related]
59. Radiographic findings in the jaws of patients with neurofibromatosis 1.
Visnapuu V; Peltonen S; Tammisalo T; Peltonen J; Happonen RP
J Oral Maxillofac Surg; 2012 Jun; 70(6):1351-7. PubMed ID: 21856061
[TBL] [Abstract][Full Text] [Related]
60. Growth behavior of plexiform neurofibromas after surgery.
Nguyen R; Ibrahim C; Friedrich RE; Westphal M; Schuhmann M; Mautner VF
Genet Med; 2013 Sep; 15(9):691-7. PubMed ID: 23598713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
